Journal article · 2026
Photoactivatable Small-Molecule PD-L1 Inhibitors for Checkpoint Blockade-based Tumor Immunotherapy
Journal of Medicinal Chemistry · Published 14 November 2026 · DOI 10.1021/acs.jmedchem.6c02082
In brief
“Photoactivatable Small-Molecule PD-L1 Inhibitors for Checkpoint Blockade-based Tumor Immunotherapy” is a 2026 journal article by Danfeng Wang and 10 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 60
- Authors
- 11
Abstract
Blocking PD-1/PD-L1 interaction shows remarkable antitumor efficacy clinically but systemic administration can cause immune-related adverse events in multiple organs from nonspecific T-cell activation, restricting the clinical safety window. Achieving spatiotemporal regulation of immune checkpoint blockadepreserving antitumor immunity while avoiding systemic toxicityis a key challenge. Prodrug strategies, particularly photocaging, enable on-demand light-triggered drug activation. Here, we… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wang, D., Jiang, B., Yang, P., Wang, H., Wang, L., Xia, G., Zhu, L., Wang, L., Xiao, Y., Sun, C., & Yang, P. (2026). Photoactivatable Small-Molecule PD-L1 Inhibitors for Checkpoint Blockade-based Tumor Immunotherapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02082
MLA 9
Wang, Danfeng, et al. “Photoactivatable Small-Molecule PD-L1 Inhibitors for Checkpoint Blockade-based Tumor Immunotherapy.” Journal of Medicinal Chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.6c02082.
Chicago
Wang, Danfeng, Binjian Jiang, Pan Yang, Hong Wang, Lili Wang, Guangqi Xia, Lili Zhu, et al. 2026. “Photoactivatable Small-Molecule PD-L1 Inhibitors for Checkpoint Blockade-based Tumor Immunotherapy.” Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02082.
Harvard
Wang, D. et al. (2026) ‘Photoactivatable Small-Molecule PD-L1 Inhibitors for Checkpoint Blockade-based Tumor Immunotherapy’, Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.6c02082.
IEEE
D. Wang et al., “Photoactivatable Small-Molecule PD-L1 Inhibitors for Checkpoint Blockade-based Tumor Immunotherapy,” Journal of Medicinal Chemistry, 2026, doi: 10.1021/acs.jmedchem.6c02082.
BibTeX
@article{wang2026photoactivatable,
title = {{Photoactivatable Small-Molecule PD-L1 Inhibitors for Checkpoint Blockade-based Tumor Immunotherapy}},
author = {Wang, Danfeng and Jiang, Binjian and Yang, Pan and Wang, Hong and Wang, Lili and Xia, Guangqi and Zhu, Lili and Wang, Liping and Xiao, Yibei and Sun, Chengliang and Yang, Peng},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c02082},
url = {https://doi.org/10.1021/acs.jmedchem.6c02082}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- PD-L1 inhibitors
- photoactivatable prodrugs
- photocaging
- immune checkpoint blockade
- cancer immunotherapy
- immune-related adverse events
- T cell effector function
- small molecule inhibitors
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Wang, D., Jiang, B., Yang, P., Wang, H., Wang, L., Xia, G., Zhu, L., Wang, L., Xiao, Y., Sun, C., & Yang, P. (2026). Photoactivatable Small-Molecule PD-L1 Inhibitors for Checkpoint Blockade-based Tumor Immunotherapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02082
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Danfeng Wang, Binjian Jiang, Pan Yang, Hong Wang, Lili Wang, Guangqi Xia, Lili Zhu, Liping Wang, Yibei Xiao, Chengliang Sun, Peng Yang.
What is the DOI of this paper?
10.1021/acs.jmedchem.6c02082, permanently at https://doi.org/10.1021/acs.jmedchem.6c02082. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.